By Richard A. Lewis, MD
The overall disappointing results of neuroprotective studies thus far should not halt promising research.
By Michael Belkin, MA, MD
By Eric H. Leung, MD, MS; Christopher Rodarte, MD; Felipe A. Medeiros, MD, PHD; and Robert N. Weinreb, MD
An overview of current methods and difficulties and a look at the future.
By Chris A. Johnson, PHD
Several questions come to my mind when dealing with someone who has severe glaucoma.
By George L. Spaeth, MD
Strategies for assisting patients who have lost vision to glaucoma.
By Kara Hanson, OD, FAAO
Research is shedding light on the degeneration of retinal ganglion cells and suggests possible means toward their recovery.
By Jeffery L. Goldberg, MD, PHD
By Gloria P. Fleming, MD
Glaucoma Today asked five physicians to share how they are managing their practices.
By Brian Flowers, MD; George R. Reiss, MD; Adam C. Reynolds, MD; Michael H. Rotberg, MD; and George Shafranov, MD
By Nthan M. Radcliffe, MD
Dr. Wiggs comments on the potential clinical applications as well as the challenges of genetic research in glaucoma.
b class="red"A WORD ON BLEBS/bbremThe following reader/author exchange is in reference to an editorial by Richard A. Lewis, MD, and an article titled “Closing the Fornix-Based Flap” by Craig Marcus, MD, and Garry P. Cond... more >
Tissue Bank International (Baltimore, MD) has announced the availability of the VisionGraft Sterile Cornea, a sterile corneal allograft for use in tectonic transplant procedures. It is ready to use at room temperature and has ... more >
ASICO LLC (Westmont, IL) debuted its Neuhann USC Glaucoma Marker: AE-1529 and Kitahara Glaucoma Punch: AE-8304 at the 2009 AAO Annual Meeting in San Francisco. The Kitahara Glaucoma Punch’s 1.0-mm X 1.0-mm square 360° ti... more >
In a phase 2a study, a Rho-kinase (ROCK) inhibitor (AR- 12286; Aerie Pharmaceuticals, Inc., Bridgewater, NJ) produced a statistically significant decrease in IOP with q.d. and b.i.d. dosing. The study enrolled 88 patients with ... more >
Research is shedding light on the degeneration of retinal ganglion cells and suggests possible means toward their recovery.
By Jeffery L. Goldberg, MD, PHD
By Eric H. Leung, MD, MS; Christopher Rodarte, MD; Felipe A. Medeiros, MD, PHD; and Robert N. Weinreb, MD
Several questions come to my mind when dealing with someone who has severe glaucoma.
By George L. Spaeth, MD
The overall disappointing results of neuroprotective studies thus far should not halt promising research.
By Michael Belkin, MA, MD
An overview of current methods and difficulties and a look at the future.
By Chris A. Johnson, PHD